Gene Query: CKAP4

Dataset Description Geneva Score
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 85.54
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 74.73
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 47.79
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 47.27
Crizotinib v. DMSO in SW480 cells 43.55
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 42.83
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 40.99
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 40.78
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 40.78
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 40.33
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 40.0
Role of CD133 molecule in WNT response and renal repair 39.57
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 39.1
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 38.74
Oncogenic MYC induces a dependency on the spliceosome in human cancer 37.79
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 37.23
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 36.58
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 35.42
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 34.94
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 34.92
Spliceosomal disruption of the non-canonical BAF complex in cancer 34.71
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 34.51
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 34.25
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 33.15
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 32.88
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 32.84
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 32.14
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 31.54
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 31.54
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 30.65
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 30.46
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 29.06
NR2F2 study 28.99
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 28.99
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 28.53
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 28.15
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 28.03
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 27.77
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 27.36
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 27.19
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 27.08
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 27.08
Differential expression of genes in AD169-infected MRC5. 27.01
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 26.95
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 26.85
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 26.85
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 26.62
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 26.46
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 26.1
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 26.1
A transcriptome-wide divergence in protein translation scales with LIN28B expression 25.69
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 25.31
RNA-seq analysis of AML cells in response to ASLAN003 25.18
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 24.94
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 24.73
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 24.73
Morphological and molecular characterization of human dermal lymphatic collectors 24.0
Gene expression changes associated with resistance to tagraxofusp (SL-401) 23.83
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 23.74
Modeling Familial Cancer with iPSC Approaches 23.68
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 23.66
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 23.6
The interplay between SOX4 and SMAD3 in the context of breast cancer 23.47
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 22.87
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 22.75
RNA-Seq analysis of breast cancer cells after shikonin treatment 22.7
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 22.5
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 22.24
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 22.11
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 22.11
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 22.0
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 21.56
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 21.48
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 21.39
SRSF2 mutations impair hematopoiesis and alter exon recognition 21.37
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 21.16
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 21.13
Human HAP1 cells before and after nutrient deprivation 21.13
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 20.89
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 20.63
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 20.53
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 20.3
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 20.3
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 20.19
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 20.19
CD86 regulates a pro-survival signal in myeloma cells 20.0
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 19.99
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 19.84
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 19.68
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 19.65
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 19.64
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 19.64
Human neutrophil genome during PMA- and E. coli encounter-induced activation 19.62
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 19.62
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 19.62
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 19.27
Metastasis in triple-negative breast cancer 19.27
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 19.12
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 18.87
Effects of rFVIIIFc on human macrophages 18.76
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 18.59
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 18.59
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 18.58
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 18.29
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 18.25
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 18.18
Proteomics identifies a marker signature of MAPKi resistance in melanoma 18.15
Gene expression changes upon drug withdrawal (Mel888 cell line) 18.15
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 18.03
Triple vectors expand AAV transfer capacity in the retina 17.92
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 17.81
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 17.79
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 17.31
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 17.29
Gene expression profiling of human and murine in vitro muscle differentiation 17.16
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 17.12
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 17.12
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 16.98
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 16.98
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 16.95
The human blood-nerve barrier transcriptome 16.89
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 16.86
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 16.66
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 16.6
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 16.48
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 16.39
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 16.38
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 16.15
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 15.92
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 15.92
Transcriptome-wide identification of CELF2 functional targets in T cells 15.88
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 15.79
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 15.74
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 15.71
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 15.62
ARID1A and ARID1B loss in HCT116 cells 15.31
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 15.3
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 15.3
SF3B1 Degron knockdown RNA-seq 15.29
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 15.22
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 15.22
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 15.2
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 15.17
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 15.16
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 15.08
Co-regulation of splicing by Rbfox1 and hnRNP M 15.08
Transcriptome wide analysis of classically and alternatively activated macrophages 15.06
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 15.03
Role of microRNAs in the interaction between Salmonella and the host cell 14.93
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 14.81
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 14.73
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 14.7
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 14.68
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 14.68
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 14.67
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 14.65
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 14.62
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 14.5
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 14.41
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 14.31
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 14.29
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 14.29
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 14.29
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 14.29
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 14.24
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 14.14
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 14.12
Global expression profiles in cardiac progenitor cells generated by ISX-9 14.04
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 14.04
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 13.98
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 13.98
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 13.96
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 13.86
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 13.85
The role of FAM46C in myeloma cells 13.82
The role of FAM46C in myeloma cells [sequencing] 13.82
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 13.7
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 13.57
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 13.57
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 13.4
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 13.36
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 13.35
Transcriptional profiling of LS1034 cells treated with tepoxalin 13.3
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 13.23
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 13.23
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 13.14
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 13.09
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 13.05
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 12.99
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 12.98
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 12.98
RNA m5C Methylation in breast cancer using MeRIP-Seq 12.93
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 12.93
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 12.85
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 12.81
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 12.81
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 12.8
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 12.8
Mitochondrial dsRNA triggers antiviral signalling in humans 12.7
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 12.64
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 12.6
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 12.56
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 12.56
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 12.52
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 12.52
RNA-seq of human aneuploid cell lines with Trisomy 21 12.49
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 12.49
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 12.46
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 12.41
RNA-seq of YB5 cells treated with Proscillaridin A 12.36
The conserved transcriptional landscapes in human spermatogenesis 12.3
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 12.29
Novel Targeting of Transcription and Metabolism in Glioblastoma 12.27
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 12.15
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 12.12
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 12.02
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 11.98
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 11.93
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 11.93
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 11.92
AMPK signaling for naïve pluripotency 11.9
AMPK signaling for naïve pluripotency [Hs] 11.9
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 11.81
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 11.68
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 11.65
Effect of BMP inhibition or stimulation of primary human keratinocytes 11.65
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 11.51
RNA transcriptome analysis during HSV-1 infection 11.46
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 11.46
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 11.44
RNA sequencing of BT142 and TS603 cell lines 11.44
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 11.41
Global analysis of alternative splicing regulated by RBM10 11.34
Uridylation by TUT4 and TUT7 marks mRNA for degradation 11.32
RNA-seq of tumor cells following angiopellosis extravasation 11.32
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 11.26
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 11.26
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 11.23
Non-coding regions are the main source of tumor-specific antigens [human] 11.16
Non-coding regions are the main source of tumor-specific antigens 11.16
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 11.14
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 11.14
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 11.07
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 11.05
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 11.03
Integrin signaling regulates YAP/TAZ to control skin homeostasis 11.02
Tpl-2 small molecule project 10.97
Tpl-2 and MEK small molecule inhibitors 10.97
TGF-β regulation of miRNA expression in pancreatic cancer 10.9
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 10.89
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 10.85
SNHG5 siRNA knock down in HCT116 cells 10.81
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 10.79
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 10.75
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 10.72
Cerebellar differentiation in Ataxia-Telangiectasia 10.71
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 10.68
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 10.67
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 10.67
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 10.63
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 10.61
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 10.61
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 10.59
Regionally specified human pluripotent stem cell-derived astrocytes 10.59
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 10.56
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 10.55
Silencing p300 in MCF7 cells to study expression and alternative splicing 10.38
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 10.35
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 10.27
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 10.22
MCF-7 as a model for functional analysis of breast cancer risk variants 10.17
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 10.12
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 10.1
Microprocessor mediates transcription termination in long noncoding microRNA genes 10.09
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 10.05
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 10.01
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 9.97
The evolution of N6-methyladenosine in primates 9.87
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 9.87
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 9.83
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 9.83
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 9.75
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 9.75
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 9.69
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 9.67
FBXW7 modulates stress response by post-translational modification of HSF1 9.67
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 9.59
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 9.53
ADAR1-editing of cellular and measles virus-derived duplex RNA 9.53
Exploring the RNA landscape of endothelial exosomes 9.53
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 9.52
RNA-seq melanoma 9.52
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 9.45
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 9.43
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 9.41
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 9.35
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 9.29
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 9.28
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 9.25
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 9.23
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 9.22
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 9.22
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 9.21
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 9.17
Widespread intronic polyadenylation diversifies immune cell transcriptomes 9.1
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 9.06
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 9.02
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 8.94
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 8.9
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 8.9
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 8.89
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 8.88
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 8.81
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 8.7
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 8.67
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 8.55
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 8.54
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 8.49
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 8.47
Ebola virus (EBOV) infection of ARPE-19 cells 8.3
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 8.3
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 8.3
Cajal bodies are linked to genome conformation 8.29
Cajal bodies are linked to genome conformation [RNA-Seq] 8.29
Energy Metabolism during Anchorage-Independence 8.19
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 8.19
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 8.17
RNA-sequencing of human tendon after injury 8.12
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 8.09
Nutritional control of protein translation 8.09
Zika virus infection reprograms global transcription of host cells to allow sustained infection 8.08
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 8.07
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 8.01
LIN28A modulates splicing and gene expression programs in breast cancer cells 8.01
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 8.0
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 7.98
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.97
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 7.95
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 7.9
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 7.9
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 7.8
Interaction between mitoNEET and NAF-1 in cancer cells 7.75
RNA-sequencing in irradiated and normal A549 cells. 7.73
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 7.7
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 7.66
Enhancer activation during EGF response 7.63
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 7.63
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 7.6
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 7.53
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 7.49
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 7.4
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 7.31
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 6.93
Genome wide miR-191 target profile determined by RIP and gene expression profiling 6.93
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 6.83
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.81
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 6.75
RNA seq comparison between scrambled and shGRP78 cells 6.75
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 6.68
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 6.68
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 6.63
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 6.63
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 6.52
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 6.35
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 6.29
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 6.18
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 6.12
Genome-wide discovery of human splicing branchpoints 6.07
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 5.97
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 5.9
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 5.89
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 5.87
CHCHD10 gene KO effect in iPSC drived motor neurons 5.81
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 5.72
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 5.69
MAIT cell RNA sequencing 5.68
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 5.53
Positively selected enhancer elements endow tumor cells with metastatic competence 5.52
Gene expression activation in CLL mediated by MSCs contact 5.38
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 5.34
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 5.32
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 5.31
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 5.28
Genome-wide discovery of human splicing branchpoints [RNAse] 4.99
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 4.96
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 4.92
IMP3 regulated gene expression in breast cancer cells 4.9
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 4.88
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 4.73
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 4.68
Identification of global XBP1s target gene expression in human prostate cancer cells 4.66
NHLRC1 re-expression in cancer cells 4.66
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 4.64
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 4.64
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 4.63
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 4.56
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 4.56
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 4.55
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 4.55
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 4.42
Gene expression profile of multiple myeloma cell lines treated with CB-5083 4.27
BACH2 in human plasma cell fate decision 4.23
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.18
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 4.14
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 3.94
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 3.86
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 3.83
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 3.7
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.6
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 3.35
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 3.31
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.28
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.24
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 3.22
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 3.14
RNA-seq of primary patient AML samples 3.08
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 3.08
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 3.08
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 3.03
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 2.87
Common inflammatory pathways between NEC and Crohn's disease 2.79
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.7
Global response to chemotherapy-induced apoptosis 2.69
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 2.67
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 2.58
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 2.52
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 2.41
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.26
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.26
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 2.24
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.21
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 2.18
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 2.12
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 2.09
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 2.08
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.05
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.97
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.97
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.84
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.83
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.82
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.76
Identification of long noncoding RNAs in T-ALL cell lines 1.75
circRNA-sequencing 1.68
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.67
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.67
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.62
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 1.57
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.41
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.41
Gene expression changes in human melanoma cell lines compared to primary melanocytes 1.36
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.34
MHC Transcriptomic landscape at haplotype-specific resolution 1.25
Clinker: visualizing fusion genes detected in RNA-seq data 1.19
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.17
Primary Human B-cell Temporal Response to CD40L Stimulation 1.16
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.16
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.16
mRNA expression in human DAOY cells 1.15
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.11
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 1.06
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.03
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.02
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.89
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.88
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.8
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.8
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.78
Finding missing proteins from epigenetically manipulated human cells 0.74
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.73
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.66
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.66
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.63
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.63
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.62
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.61
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.6
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 0.6
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.59
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.58
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.57
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.45
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.45
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.44
SOX11 knockdown in B-ALL cell lines 0.44
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.42
Specific molecular signatures underlie response to decitabine in CMML 0.42
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.33
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.31
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.21
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.18
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 0.13
BET bromodomain inhibition 0.13
Total RNA-Seq data from leukemic patients with complex structural variants 0.13
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.12
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.11
Transcriptomic analysis of human macrophages in 3D 0.1
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.08
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.06
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.05


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation